# US 2012/0253294 A1 · Method and system for treatment of internal nasal valves

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0253294 A1
- Document ID: US20120253294A1
- Status: Published application
- Kind: A1
- Application number: 13/506,260
- Filed: 2012-04-06
- Published: 2012-10-04
- Earliest claimed: 2005-09-22
- Inventors: Christopher Philip Nyte
- Web page: https://patentgrep.com/patent/US20120253294A1

## CPC

- A61F 2/186: {Nose parts}
- A61M 5/329: {characterised by features of the needle shaft}
- A61F 2002/30583: {filled with hardenable fluid, e.g. curable in-situ}
- A61F 2210/0085: hardenable in situ, e.g. epoxy resins
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

Internal nasal valve involves injecting a biomaterial filler into the internal nasal valve of the patient. The injected biomaterial filler in the internal nasal valve increases an internal nasal valve angle.

## Claims

### Claim 1

A system for non-surgically treating an internal nasal valve of a patient comprising: a control syringe; and a 2-inch, 25 gauge thin-thin wall short bevel needle, wherein the needle comprises: a 10-20 degree bend at the terminal portion of the needle about 0.25 inches from the terminal end; and a hub for fluidly coupling to the control syringe.

### Claim 2 (depends on 1)

The system of claim 1, wherein the control syringe is a 1.0 cc control syringe.

### Claim 3 (depends on 1)

The system of claim 1, wherein the control syringe is a 0.3 cc control syringe.

### Claim 4 (depends on 1)

The system of claim 1, wherein the needle comprises a 15 degree bend at the terminal portion of the needle about 0.25 inches from the terminal end.

### Claim 5 (depends on 1)

The system of claim 1, further comprising a straight needle fluidly coupled to a hub, the straight needle capable of fluidly coupling to the 2-inch needle, and the hub capable of fluidly coupling to the control syringe.

### Claim 6 (depends on 1)

The system of claim 1, wherein the needle is stainless steel.

### Claim 7 (depends on 1)

The system of claim 1, wherein the hub is stainless steel.

### Claim 8 (depends on 12)

The system of claim 12, wherein the control syringe is pre-loaded with a biomaterial filler.

### Claim 9 (depends on 8)

The system of claim 8, wherein the biomaterial filler is a gel cartilage matrix.

### Claim 10 (depends on 8)

The system of claim 8, wherein the biomaterial filler is a calcium hydroxylapatite gel.
